This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Based in North Kansas City, MO, Cerner Corporation (CERN) provides healthcare information technology (HCIT) solutions worldwide. The company offers software and hardware solutions that give healthcare providers secure access to clinical, administrative and financial data in a short time. As of February 2018, its products were in use at more than 27,000 facilities around the world. The company had more than 28,000 employees globally, with over 13,000 in Kansas City, Missouri. More than 28,000 Cerner associates are currently employed in 26 countries worldwide
CPSI vs. CERN: Which Stock Is the Better Value Option?
by Zacks Equity Research
CPSI vs. CERN: Which Stock Is the Better Value Option?
Cerner (CERN) Q4 Earnings Meet Estimates, Revenues Miss
by Zacks Equity Research
Cerner (CERN) gains from solid segmental revenues in fourth-quarter 2018. However, the company's 2019 guidance disappoints.
Cerner (CERN) Q4 Earnings Meet Estimates
by Zacks Equity Research
Cerner (CERN) delivered earnings and revenue surprises of 0.00% and -1.99%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Cerner (CERN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cerner (CERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cerner (CERN) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Cerner's (CERN) fourth-quarter 2018 results are likely to be hurt by year-over-year decline in bookings; Q4 guidance promising.
Stock Market News For Jan 18, 2019
by Zacks Equity Research
Benchmarks ended in the green on Thursday, extending the streak of gains to three days on the trot.
Cerner Picked by Remi Vista for Behavioral Health Technology
by Zacks Equity Research
Apart from Cerner Integrated, Cerner's (CERN) revenue cycle solutions will help Remi Vista's financial operations.
Cerner (CERN) Teams Up With Nebraska-Based LRHC, Shares Up
by Zacks Equity Research
Cerner's (CERN) coveted Millennium platform has seen rising demand in recent times.
Cerner & Christiana Care Unite to Offer Bariatric Services
by Zacks Equity Research
Cerner (CERN) likely to gain from increased obesity rates in the United States.
Stock Market News For Jan 4, 2019
by Zacks Equity Research
Markets crashed on Thursday following Apple???s CEO Tim Cook???s announcement that the tech mega-cap had slashed its revenue guidance for the first quarter.
Here's Why You Should Hold on to Cerner (CERN) Stock for Now
by Zacks Equity Research
A bullish guidance for 2018 and a series of latest developments make Cerner (CERN) a promising investment pick.
Cerner (CERN) Collaborates With McKesson's CoverMyMeds
by Zacks Equity Research
Cerner's (CERN) ePrescribe workflow solution is likely to partner with CoverMyMeds' RxBenefit Clarity solution for prescription price transparency.
Stock Market News For Dec 18, 2018
by Zacks Equity Research
U.S. stocks collapsed for the second straight day as investors remained wary of the Fed's widely expected fourth rate hike for 2018
Cerner's (CERN) Millennium Picked by Mid-Valley Hospital
by Zacks Equity Research
Cerner's (CERN) EHR platforms have seen a series of developments in recent times.
CPSI or CERN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CPSI vs. CERN: Which Stock Is the Better Value Option?
Cerner (CERN) Looks Good: Stock Adds 5.1% in Session
by Zacks Equity Research
Cerner (CERN) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Cerner's (CERN) Q3 Earnings Match Estimates, Bookings Up Y/Y
by Zacks Equity Research
Cerner (CERN) gains from strong segmental revenues in the third quarter. Guidance for 2018 is impressive.
Cerner (CERN) Q3 Earnings Match Estimates
by Zacks Equity Research
Cerner (CERN) delivered earnings and revenue surprises of 0.00% and -1.60%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Medical Product Earnings Lineup for Oct 25: SYK, CERN & More
by Zacks Equity Research
Long-term potential of the Medical Products industry looks promising at the moment amid certain short-term geopolitical insecurities.
Cerner (CERN) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Cerner (CERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Veeva Launches Vault SiteDocs for Regulatory Documentation
by Zacks Equity Research
Veeva's (VEEV) Vault SiteDocs Platform conducts high-quality, compliant clinical trials with greater visibility to researchers.
What's in Store for Cerner (CERN) This Earnings Season?
by Zacks Equity Research
Cerner's (CERN) third-quarter 2018 results are likely to be hurt by soft segmental results; guidance promising.
Varian (VAR) Buys Noona to Boost Oncology Software Services
by Zacks Equity Research
Varian's (VAR) latest move provides it significant exposure to the cloud-based oncology services market.
Cerner's Millennium Platform Integrated at McLaren Hospital
by Zacks Equity Research
Cerner's (CERN) Millennium HCIT platform sees a series of developments in 2018.
Here's Why You Should Hold on to athenahealth (ATHN) for Now
by Zacks Equity Research
athenahealth (ATHN) likely to gain from focus on cloud-based healthcare services.